Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1;25(1):367.
doi: 10.1186/s12886-025-04179-5.

Decreased miR-455-3p promotes diabetic retinopathy progression via modulating retinal endothelial proliferation and apoptosis

Weipeng Jiang  1 , Shouyan Xu  2 , Shanshan Lu  1 , Ailing Dong  1 , Neng Jiang  3
Affiliations

Decreased miR-455-3p promotes diabetic retinopathy progression via modulating retinal endothelial proliferation and apoptosis

Weipeng Jiang et al. BMC Ophthalmol. .

Abstract

Background: Diabetic retinopathy (DR) is one of the common ocular complications of diabetes. Recent studies have also found that miR-455-3p is dysregulated in DR. However, its underlying mechanisms warrant further investigation.

Objective: This study focused on the clinical value of miR-455-3p and its regulatory mechanisms in DR.

Materials and methods: This study recruited 130 patients with DR and 105 healthy individuals. HRMECs treated with high glucose were used to simulate DR conditions. The expression of miR-455-3p and Integrin beta 1(ITGB1) were assessed by qRT-PCR while the target relationship between them was validated via Dual-luciferase reporter assay. ROC curve was utilized for the diagnostic performance. CCK-8 and flow cytometry were employed for proliferation and apoptosis measurement while ELISA was used for inflammation.

Results: Serum miR-455-3p was found to be distinctly downregulated in patients with DR. The expression of serum miR-455-3p was negatively associated with HbA1c levels in patients with DR. The miR-455-3p also exhibited strong diagnostic potential for distinguishing patients with DR from healthy individuals. In high glucose-induced HRMECs, miR-455-3p was significantly downregulated. miR-455-3p can target and negatively regulate ITGB1, thereby inhibiting the proliferation and inflammation of HRMECs induced by high glucose and promoting cell apoptosis.

Conclusion: Decreased miR-455-3p promotes diabetic retinopathy progression via negative regulation on ITGB1.

Clinical trial number: Not applicable.

Keywords: ITGB1; Diabetic retinopathy; Proliferation; miR-455-3p.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Taizhou First People’s Hospital before the study began. The written informed consent has been obtained from the participants involved. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Expression of miR-455-3p and correlation with HbA1c. (A) Relative expression of serum miR-455-3p in DR (n = 130) compared to Control (n = 105). (B) The HbA1c level in participants. (C) Correlation analysis of miR-455-3p and HbA1c levels. ### P < 0.001
Fig. 2
Fig. 2
The ROC curve of serum miR-455-3p
Fig. 3
Fig. 3
The regulatory effect of miR-455-3p on proliferation and apoptosis. (A) Relative expression of miR-455-3p. (B-C) The effect of miR-455-3p on proliferation. (D) The effect of miR-455-3p on apoptosis. (E-F) The content of TNF-α and IL-1β. # P < 0.05, ## P < 0.01, ### P < 0.001
Fig. 4
Fig. 4
Potential target of miR-455-3p. (A) Targets prediction with 3 databases. (B) The PPI network assembled based on common targets. (C) Predicted interactive sites and validation in luciferase reporter system. (D) Relative expression of ITGB1. ### P < 0.001
Fig. 5
Fig. 5
Effect of miR-455-3p targeting ITGB1 on cells in the DR model. (A) RT-qPCR was used to detect the expression of ITGB1 mRNA after transfection/transfection with co-transfection. (B) CCK-8 was used to detect the changes in cell proliferation. (C) The apoptosis experiment was used to detect the apoptosis rate of cells in each group. ## P < 0.01, ### P < 0.001
See this image and copyright information in PMC

References

    1. Chen Q, Chen J, Liu YN, Qi SH, Huang LY. Exosome-based drug delivery systems for the treatment of diabetes and its complications: current opinion. Extracell Vesicles Circ Nucl Acids. 2023;4(3):502–17. - PMC - PubMed
    1. Grochowski ET, Pietrowska K, Godlewski A, Gosk W, Buczynska A, Wojnar M et al. Simultaneous comparison of aqueous humor and serum metabolic profiles of diabetic and nondiabetic patients undergoing cataract Surgery-A targeted and quantitative metabolomics study. Int J Mol Sci 2023;24(16). - PMC - PubMed
    1. Pelikanova T. [Diabetic retinopathy: pathogenesis and therapeutic implications]. Vnitr Lek. 2016;62(7–8):620–8. - PubMed
    1. Millan I, Desco MDC, Torres-Cuevas I, Perez S, Pulido I, Mena-Molla S et al. Pterostilbene prevents early diabetic retinopathy alterations in a rabbit experimental model. Nutrients. 2019;12(1). - PMC - PubMed
    1. Wang M, Zhou X, Liu DN, Chen J, Zheng Z, Ling S. Development and validation of a predictive risk model based on retinal geometry for an early assessment of diabetic retinopathy. Front Endocrinol (Lausanne). 2022;13:1033611. - PMC - PubMed

LinkOut - more resources